Biltmore Family Office, LLC
Family OfficePosition in HRTX — Heron Therapeutics, Inc. /De/
CIK 1731123
CHARLOTTE, NC
Position in HRTX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$43,000
-$37,000 QoQ
Shares Held
100,000
0.0% QoQ
Ownership
0.053%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#58
of 161 holders
Holding Since
Mar 2023
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in HRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Biltmore Family Office, LLC holds $63,930 across 2 Biotechnology names. HRTX ranks #1 (67.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HRTX |
Heron Therapeutics, Inc. /De/
This page
|
100,000 | $43,000 | |
| 2 | CELU |
Celularity Inc
|
35,000 | $20,930 |
All Filings in HRTX
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $43,000 | 100,000 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $80,000 | 100,000 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $130,000 | 100,000 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $126,000 | 100,000 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $210,036 | 101,467 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $223,227 | 101,467 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $155,244 | 101,467 | Shares | Sole | 2025-02-12 | |
| 2023-09-30 | $16,917 | 16,425 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $19,053 | 16,425 | Shares | Sole | 2023-08-07 | |
| 2023-03-31 | $24,613 | 16,300 | Shares | Sole | 2023-05-12 | |
| No filing history on record for this holder in this stock. | ||||||